Conn’s Syndrome, which is also referred to as primary aldosteronism, is caused by excess production of aldosterone hormone in the bloodstream. Conn’s Syndrome occurs when adrenal glands, which are small triangular-shaped glands that regulate metabolism, produce too much aldosterone. Sometimes, primary aldosteronism results from harmless or noncancerous growths in one or both adrenal glands.
On rare occasions, it is inherited. In irregular cases, dangerous cancers in one or both adrenal glands (Simone et al., 2019). The disease was named after J. W. Conn, who discovered the disease in 1955 in a hypertension patient. Primary aldosteronism typically appears with low potassium levels in the blood and hypertension. If left untreated, hypertension can cause heart failure and stroke. On the other hand, low potassium levels can cause heartbeat irregularities.
Conn’s Syndrome is detected by measuring the degrees of hormones like aldosterone and renin, and electrolytes, such as sodium and potassium, in patients with hypertension. Computerized Tomography (CT) scan and Magnetic Resonance Imaging (MRI) may be used to rule out adrenal gland tumors. Urine samples can be used to check for high aldosterone levels (Christakis et al., 2018). Patients who have adrenal masses possibly should be evaluated for Conn’s Syndrome assuming that they are known to have circulatory strain issues. Assume patients with an adrenal mass are found to have a unique test known as adrenal vein.
Conn’s Syndrome appears with an increase in blood pressure which becomes resistant to the normal treatment for hypertension. Some of the commons signs of Conn’s Syndrome are:
- Excessive thirst.
- Lack of muscle strength.
- Frequent vomiting.
- Muscle twitching and cramps.
- Eyesight problems.
Primary aldosteronism treatment involves medications like spironolactone or eplerenone, in the event that both the adrenal glands produce the condition (Conn’s Syndrome). However, if it results from one adrenal gland (unilateral adrenalectomy), then removing that gland is an alternative to its treatment (Christa et al., 2019). Adrenal vein inspecting is compulsory before the adrenal organ with the mass is eliminated since, in dependent upon 33% of patients, the issue can originate from both or the contrary adrenal organ. This medical procedure is quite often done laparoscopically. Respective hyperplasia is treated with diuretics (water pills), which assist with overseeing liquid development in the body. Optional hyperaldosteronism is most frequently treated with drugs. Other measures to curb Conn’s Syndrome include frequent exercise, reducing sodium in your diet, limiting alcohol intake, and quitting smoking can be put in place to.
If it is not treated early, Conn’s Syndrome can cause a rise in the blood pressure to levels that may be harmful to the victim’s health. Imbalances in electrolytes in the blood and hypertension can cause severe complications to the victim. Such complications may include kidney failure, heart attack, temporary paralysis, stroke, and irregular heartbeats.
Most patients have a fast and predictable recuperation from the medical procedures after therapy. Hypertension has extraordinarily worked on most cases. However, even after a medical procedure, casualties might have hypertension. They might require drugs for hours or weeks until their blood pressure gets back to normal. The justification behind this isn’t completely perceived. It could be the consequence of kidney harm from essential hyperaldosteronism. Casualties should keep on seeing their medical services supplier after therapy so they can screen their circulatory strain and electrolytes levels.
References
Christa, M., Weng, A. M., Geier, B., Wörmann, C., Scheffler, A., Lehmann, L., … & Köstler, H. (2019). Increased myocardial sodium signal intensity in Conn’s Syndrome detected by 23Na magnetic resonance imaging. European Heart Journal-Cardiovascular Imaging, 20(3), 263-270.
Christakis, I., Livesey, J. A., Sadler, G. P., & Mihai, R. (2018). Laparoscopic adrenalectomy for conn’s Syndrome is beneficial to patients and is cost effective in England. Journal of Investigative Surgery, 31(4), 300-306.
Simone, G., Anceschi, U., Tuderti, G., Misuraca, L., Celia, A., De Concilio, B., … & Gallucci, M. (2019). Robot-assisted partial adrenalectomy for the treatment of conn’s Syndrome: surgical technique, and perioperative and functional outcomes. European Urology, 75(5), 811-816.